Degen J L
Children's Hospital Research Foundation, Children's Hospital Medical Center, Cincinnati, Ohio 45229-3039, USA.
Thromb Haemost. 2001 Jul;86(1):130-7.
Nearly all of the genes encoding the established coagulation and fibrinolytic factors have been successfully altered or disrupted in transgenic mice. Although comprehensive studies of each of these gene-targeted mouse lines are still ongoing, the initial findings have significantly refined our understanding of the roles of selected hemostatic factors in vivo, and occasionally altered long-standing concepts. This review summarizes some of the progress that has been made in the generation and phenotypic characterization of mice lacking key hemostatic factors, including coagulation, fibrinolytic, platelet and endothelial cell-associated factors. New insights regarding the role(s) and interplay of hemostatic factors that have emerged from detailed studies of mice carrying multiple deficits in coagulation and fibrinolytic system components are highlighted.
几乎所有编码已确定的凝血和纤溶因子的基因都已在转基因小鼠中成功改变或破坏。尽管对每一种基因靶向小鼠品系的全面研究仍在进行中,但初步研究结果已显著完善了我们对特定止血因子在体内作用的理解,偶尔还改变了长期以来的观念。本综述总结了在缺乏关键止血因子(包括凝血、纤溶、血小板和内皮细胞相关因子)的小鼠的生成和表型特征方面所取得的一些进展。文中强调了对凝血和纤溶系统成分存在多种缺陷的小鼠进行详细研究后,在止血因子的作用及其相互作用方面所获得的新见解。